https://clinicaltrials.gov/ct2/show/NCT01712438?type=Intr&cond=hemophilia&lupd_s=02%2F27%2F2019&lupd_d=14
Condition : Severe Hemophilia A
Intervention : Biological: Human cl rhFVIII
Sponsor : Octapharma
Active, not recruiting
Human-cl-rhFVIII in Previously Untreated Patients
NCT01712438
Tue, 23 Oct 2012 12:00:00 EDT
Last Update Posted: 03/13/19 10:19AM
